A Cloud Computing Platform for Scalable Relative and Absolute Binding Free Energy Prediction: New Opportunities and Challenges for Drug Discovery

16 October 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Free energy perturbation (FEP) has become widely used in drug discovery programs for binding affinity prediction between candidate compounds and their biological targets. Simultaneously limitations of FEP applications also exist, including but not limited to, the high cost, long waiting time, limited scalability and application scenarios. To overcome these problems, we have developed a scalable cloud computing platform (XFEP) for both relative and absolute free energy predictions with refined simulation protocols. XFEP enables large-scale FEP calculations in a more efficient, scalable and affordable way, e.g. the evaluation of 5,000 compounds can be performed in one week using 50-100 GPUs with a computing cost approximately corresponding to the cost for one new compound synthesis. Together with artificial intelligence (AI) techniques for goal-directed molecule generation and evaluation, new opportunities can be explored for FEP applications in the drug discovery stages of hit identification, hit-to-lead, and lead optimization with R-group substitutions, scaffold hopping, and completely different molecule evaluation. We anticipate scalable FEP applications will become widely used in more drug discovery projects to speed up the drug discovery process from hit identification to pre-clinical candidate compound nomination.

Keywords

free energy perturbation
drug selectivity
core hopping
scaffold hopping
macrocycle design
R-group substitutions
drug resistance

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.